The global farm animal drug market is on a strong growth trajectory, with an anticipated market value of USD 19,442.9 million by the end of 2024. Recent projections indicate that the market will continue its steady expansion at a Compound Annual Growth Rate (CAGR) of 5.5% from 2024 to 2034, ultimately reaching a valuation of USD 33,211.3 million by 2034.
Key Industry Highlights:
Concerns Over Side Effects Prompt Industry Reflection
Despite the market’s growth, rising concerns regarding side effects from farm animal drugs are raising alarms within the industry. Many farmers, particularly in underdeveloped regions, remain unaware of prevalent diseases and may resort to home remedies for their livestock. This practice, coupled with increasing apprehensions about antibiotic resistance, is posing significant barriers to the sector’s expansion.
Innovations Addressing Health Challenges
In response to these health challenges, the industry is witnessing remarkable innovations in farm animal drugs. Technological advancements, including the introduction of monoclonal antibodies, stem cells, and digital technologies, are enhancing treatment options for farm animals. Additionally, a surge in the production of anti-infective drugs reflects the market’s proactive measures to combat the pressing issues of antimicrobial resistance (AMR).
The Threat of Antimicrobial Resistance
The growing concern over antimicrobial resistance is influencing drug development and usage practices across the industry. Infections caused by AMR can lead to prolonged hospital stays, reduced surgical protections, and increased treatment costs, thereby jeopardizing the health of farm animals and the profitability of the agricultural sector.
As the global farm animal drug market evolves, stakeholders are urged to remain vigilant about health practices, explore innovative solutions, and address the challenges posed by antibiotic resistance. The future of this sector will depend on a balanced approach that prioritizes animal health while embracing advancements in pharmaceutical development.
Key Takeaways from the Farm Animal Drug Market:
- The farm animal drug market is expected to register a CAGR of 5.5%, reaching a valuation of US$ 33,211.3 million by 2034.
- The anti-infective segment is anticipated to dominate the market, holding a market share of 37.7% in 2024.
- The market in the United States is estimated to surge at a CAGR of 5.7% through 2034.
- The market in Germany is estimated to rise at a CAGR of 4.6% during the forecast period.
- The market in the United Kingdom is predicted to develop at a CAGR of 5.3% between 2024 and 2034.
Discover the Rising Demand for Farm Animal Drug: Dive into Our Full Report for Detailed Trends and Insights!
Competitive Landscape:
The farm animal drug market is dynamic and diverse, with established players competing for maximum market share by introducing advanced product lines. Manufacturers have gained consumer trust in recent years by conducting surveys and campaigns in villages to understand farmers’ concerns regarding animal drugs.
Recent Development:
In 2024, the major breakthrough was achieved by the Indian Council of Agricultural Research (ICAR) in the fight against the Lumpy Skin Disease (LSD) virus, which has caused significant damage to the country’s livestock. The council plans to launch a commercially viable vaccine, which has been indigenously developed to tackle the deadly virus. The livestock industry is set to benefit significantly from this vaccine, as it is expected to reduce animal mortality rates and bring down the incidence of LSD infection.
Leading Farm Animal Drug Brands:
- Bayer AG
- Boehringer Ingelheim GmbH
- Zoetis, Inc.
- Ceva Santé Animale
- Dechra Pharmaceuticals PLC
- Elanco Animal Health (Sub. Eli Lilly)
- Merck Animal Health
- Virbac SA
- Vetoquinol SA
- Intas Animal Health
- Alembic Animal Health
- Sequent Scientific
- Hester Biosciences
- Ashish Life Sciences
- Ouro Fino Saude Animal (Ourofino)
- Zydus Animal Health (Sub. Cadila Healthcare Ltd)
- Phibro Animal Health Corporation
- Nippon Zenyaku Kogyo Co., Ltd
- Norbrook
- Kyoritsu Seiyaku Corporation
Key Segments of Market Report:
By Product:
Depending on the product type, the sector is categorized into anti-infective, parasiticides, anti-inflammatory, anesthetics, analgesics, hormones, and related products. Moreover, parasiticides are further divided into endo-parasiticides, ecto-parasiticides, and endectocides.
By Animal Type:
The animal type segment is bifurcated into livestock animals and equine. Livestock animals include ruminants, swine, and poultry.
By Route of Administration:
Route of administration of farm animal drugs include oral, parenteral, topical, and others.
By Distribution Channel:
Farm animal drugs are distributed through veterinary hospitals, veterinary clinics, pharmacies drug stores, and other channels.
By Region:
Regional analysis of the industry is conducted in North America, Latin America, Europe, South Asia, East Asia, Oceania, and the Middle East and Africa.
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube